Medical Services Expenditures by Disease: Diseases of the Digestive System Price Index, Blended Account Basis (DIDISYPIBLEND) | FRED | St. Louis Fed
- Rows
- 22
- Columns
- 2
- Data range
- 2000-01-01 to 2021-01-01
Graph and download economic data for Medical Services Expenditures by Disease: Diseases of the Digestive System Price Index, Blended Account Basis (DIDISYPIBLEND) from 2000 to 2021 about digestion, disease, healthcare, medical, health, expenditures, services, price index, indexes, price, and USA.
AI analysis
Analysis: Medical Services Expenditures by Disease — Digestive System Price Index
1. Dataset Overview and Value
This dataset, sourced from the Federal Reserve Bank of St. Louis's FRED database (fredgraph.csv?id=DIDISYPIBLEND), tracks a price index for medical services expenditures related to digestive system diseases on a "blended account basis," spanning annual observations from 2000 to 2021. As a FRED-published series, it carries strong credibility for economic and healthcare research, benefiting from FRED's rigorous vintage-controlled, standardized data pipeline. The blended account basis suggests this index aggregates across payer types (e.g., private insurance, Medicare, Medicaid, out-of-pocket), making it valuable for studying disease-specific healthcare inflation trends. Its primary value for correlation studies lies in examining how digestive disease treatment costs move relative to broader CPI/medical CPI benchmarks, other disease-specific price indices, GDP healthcare spending shares, or policy events (e.g., ACA implementation, pandemic-era disruptions).
2. Data Quality Observations
The dataset is exceptionally clean at face value: zero null cells across both columns, and each of the 22 rows contains distinct values for both the date and the index measure — consistent with a well-curated single annual time series with no missing years in the 2000–2021 window. Duplicate-row assessment is marked as pending Phase D recomputation, so that check should be finalized before relying on uniqueness assumptions, though with only 22 rows and 22 distinct dates, duplication risk appears inherently low. One limitation is the very small sample size (22 observations), which constrains statistical power for any rigorous correlation or regression analysis — findings should be treated as directional rather than robust.
3. Key Column Distributions
The core metric, DIDISYPIBLEND, ranges from 51.86 to 116.49, with a mean of 83.27 and median of 82.03 — the close proximity of mean and median, combined with a low skewness of 0.141, indicates a fairly symmetric, near-normal distribution without significant outliers or long tails. The interquartile range (Q1=68.02, Q3=97.39) spans roughly 29 points, and the standard deviation of 19.72 relative to the mean suggests substantial variability (~24% coefficient of variation) — expected given this is a price index tracked over two decades of healthcare cost inflation, likely reflecting a generally upward secular trend from the 2000 baseline near 51.86 toward higher values by 2021.
4. Recommended Join Keys
The observationdate column is the clear and only viable join key, formatted as a standard Date type with annual granularity (YYYY-01-01). For cross-dataset correlation, this should be matched against other annual time series using year-aligned dates — analysts should verify that comparison datasets use the same annual convention (calendar year vs. fiscal year) and consider resampling higher-frequency data (monthly/quarterly) to annual averages or year-end snapshots to ensure proper alignment.
5. Suggested Complementary Datasets
Strong candidates for correlation analysis include: (a) other FRED disease-specific price indices (e.g., cardiovascular, respiratory, musculoskeletal disease expenditure indices) to compare relative inflation rates across disease categories; (b) the broader Medical Care CPI (CPIMEDSL) or overall CPI-U to contextualize digestive-disease-specific inflation against general healthcare and economy-wide inflation; (c) CMS National Health Expenditure data on digestive disease prevalence, hospitalization rates, or utilization volumes to distinguish price-driven vs. volume-driven cost growth; (d) obesity/diet-related public health indicators (CDC BRFSS data) given digestive disease linkages to lifestyle factors; and (e) insurance coverage or ACA enrollment metrics to explore whether payer-mix shifts correlate with blended-basis price movements.
Columns
- observation_date (date)
- DIDISYPIBLEND (decimal)